News & Information
At Memorial Sloan Kettering, our leading edge research is constantly advancing what we know about cancer and new discoveries are improving care for patients here, and all over the world. In News and Information, you will find information about our groundbreaking work and the dedicated professionals who make it all happen.
For Journalists
Connect with us to reach MSK experts for media inquiries, source story ideas and download MSK digital assets.
MSK received top rankings in gynecology, urology, and several subspecialties
MSK is proud to join with National Cancer Institute (NCI)-designated cancer centers and other organizations to launch an awareness initiative urging the nation’s physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track.
In the News
A phase II trial of the targeted therapy trastuzumab deruxtecan (Enhertu®) has found that the drug shrinks tumors in more than half of people with advanced lung cancer driven by the protein HER2.
Get to know Abby Hawk, who got a tattoo of Memorial Sloan Kettering after being treated there for neuroblastoma.
Learn about why MSK patient Kelly Lawlor, who was diagnosed with thyroid cancer in 2016, chose watchful waiting over surgery.
Stay Connected with MSK
News Releases
New data published in the New England Journal of Medicine (NEJM) and featured at the European Society for Medical Oncology (ESMO) Congress 2021 highlights a promising new treatment for individuals with HER2-mutant non-small cell lung cancer (NSCLC).
President Biden announced the appointment of seven distinguished clinicians and researchers to the National Cancer Advisory Board. Memorial Sloan Kettering Cancer Center’s Luis Alberto Diaz, Jr., MD, was among those appointed.
Memorial Sloan Kettering Cancer Center (MSK) has appointed Tracy Gosselin, PhD, RN, AOCN, NEA-BC, FAAN, as Senior Vice President, Chief Nurse Executive, and Chair of Nursing effective November 2021.
Media Coverage
Trastuzumab deruxtecan (T-DXd) achieves durable responses in individuals who have received prior treatment for metastatic non-small-cell lung cancer (NSCLC) harboring HER2 mutations, suggests the DESTINY-Lung01 trial. The results were presented at the ESMO Congress 2021 by MSK’s Bob Li and simultaneously published in The New England Journal of Medicine.
Monday, September 20, 2021
Tracy Gosselin, PhD, RN, was appointed senior vice president, chief nurse executive and chair of nursing at Memorial Sloan Kettering Cancer Center.
Friday, September 17, 2021
MSK’s Nancy Y. Lee, David G. Pfister and Richard J. Wong authored an op-ed on the importance of the HPV vaccine and encouraging parents and caregivers to create a plan to have their children vaccinated.
Friday, September 17, 2021
News from the Lab
Experiments with zebrafish and human pluripotent stem cells reveal the necessary ingredients, besides genetic mutations, that fuel the development of melanoma.
A new study shows how evolution and natural selection influence clonal hematopoiesis, an aging-related blood condition that increases the risk of blood cancer and cardiovascular disease.
A blood-based test identifies patients in whom immunotherapy may ‘LAG.’
MSK News
A new technology shows great promise for imaging and treating advanced forms of prostate cancer.
MSK researchers are learning more about how cancer cells can survive undetected for years only to return in new places. These insights will guide future therapies.
When cancer cells change, special testing enables new therapies to keep the disease at bay. Garth Atchley was diagnosed with lung cancer that spread to his brain four years ago, and he’s still running marathons.
2020 Annual Report: Meeting the Moment
MSK researchers like physician-scientist Karuna Ganesh are using an innovative technology called organoids to unlock the mysteries of cancer metastasis.
In her new role as Chief Health Equity Officer, gynecologic cancer surgeon Carol Brown is leading a new commitment to reducing cancer disparities. Dr. Brown spoke with NBC’s Today show anchor Al Roker about raising awareness about these disparities.
Memorial Sloan Kettering staff, patients, and donors stepped up in extraordinary ways during the COVID-19 pandemic. Meet just some of these heroes.